NV
NVO
HealthcareNovo Nordisk A/S
Drug Manufacturers - General
Total Trades
27
Unique Traders
8
Purchases / Sales
18/9
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Feb 13, 2026 |  Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $49.57 | $37.96 | -23.4% | -20.6% | |
Oct 31, 2025 |  Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $49.46 | $49.35 | -0.2% | -0.4% | |
Oct 30, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $50.04 | $49.35 | -1.4% | -1.9% | |
Oct 30, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $50.04 | $49.35 | -1.4% | -1.9% | |
Oct 15, 2025 |  Marjorie Taylor Greene | Stock | Buy | $1,001 - $15,000 | $56.72 | $48.26 | -14.9% | -15.9% | |
Sep 11, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $54.30 | $56.93 | +4.8% | +5.3% | |
Aug 28, 2025 | Marjorie Taylor Greene | Stock | Buy | $1,001 - $15,000 | $56.11 | $55.61 | -0.9% | -3.2% | |
Aug 19, 2025 | Marjorie Taylor Greene | Stock | Buy | $15,001 - $50,000 | $54.78 | $61.85 | +12.9% | +9.4% | |
Aug 4, 2025 |  Scott Scott FranklinR | Stock | Buy | $15,001 - $50,000 | $48.27 | $56.74 | +17.6% | +15.6% | |
Aug 4, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $48.27 | $56.74 | +17.6% | +15.6% | |
Aug 4, 2025 | Scott Scott FranklinR | Stock | Buy | $1,001 - $15,000 | $48.27 | $56.74 | +17.6% | +15.6% | |
Aug 4, 2025 | Scott Scott FranklinR | Stock | Buy | $1,001 - $15,000 | $48.27 | $56.74 | +17.6% | +15.6% | |
Jul 11, 2025 |  Michael T. McCaulR | Stock | Sell | $1,001 - $15,000 | $68.16 | $50.51 | -25.9% | -28.1% | |
Jul 10, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $70.22 | $50.51 | -28.1% | -29.9% | |
Jun 27, 2025 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $67.75 | $70.90 | +4.7% | +1.0% | |
Jun 16, 2025 | Michael T. McCaulR | Stock | Buy | $15,001 - $50,000 | $76.16 | $66.29 | -13.0% | -16.8% | |
Jun 9, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $74.62 | $68.91 | -7.6% | -12.0% | |
May 8, 2025 |  Laurel LeeR | Stock | Sell | $1,001 - $15,000 | $64.13 | $73.80 | +15.1% | +9.0% | |
Mar 27, 2025 | Scott Scott FranklinR | Stock | Buy | $15,001 - $50,000 | $68.28 | $61.39 | -10.1% | -7.2% | |
Mar 27, 2025 | Scott Scott FranklinR | Stock | Buy | $1,001 - $15,000 | $68.28 | $61.39 | -10.1% | -7.2% | |
Mar 20, 2025 |  Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $76.68 | $57.43 | -25.1% | -18.5% | |
Mar 20, 2025 | Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $76.68 | $57.43 | -25.1% | -18.5% | |
Dec 23, 2024 | Michael T. McCaulR | Stock | Buy | $100,001 - $250,000 | $86.33 | $78.41 | -9.2% | -11.2% | |
Dec 23, 2024 | Michael T. McCaulR | Stock | Buy | $50,001 - $100,000 | $86.33 | $78.41 | -9.2% | -11.2% | |
Oct 29, 2024 |  Valerie HoyleD | Stock | Buy | $1,001 - $15,000 | $108.98 | $103.28 | -5.2% | -8.2% |
Recent News
Hims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams
Benzinga-Invalid Date
Novo Nordisk Is Under Pressure - And Trading At A Discount
SeekingAlpha-Invalid Date
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough?
SeekingAlpha-Invalid Date
Eli Lilly Trumps Novo Nordisk In GLP-1 Race: Multi-Year Growth Prospects
SeekingAlpha-Invalid Date
Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
SeekingAlpha-Invalid Date